Eleanor Richards - Manchester Cancer Research Centre Eleanor Richards is an Obstetrics and Gynaecology Registrar and Clinical Research Training Fellowship PhD student. Her research focuses on endometrial cancer – the most common gynaecological cancer in the UK – with the aim of predicting which individuals are most at risk so that targeted prevention strategies can be implemented.

Meet Eleanor Richards, an MCRC PhD student & O&G Registrar dedicated to preventing endometrial cancer.

From data coding to co-creating health campaigns with underrepresented communities, Eleanor is making a real-world impact. 🩺✨

Read her story: 🔗 https://ow.ly/pHtL50YsV4b

🎓 PhD job opportunity. Join our team of Science Communications Ambassadors!

✔️ Paid role
✔️ Full training provided
✔️ Create digital content
✔️ Inspire others to consider a PhD

Perfect for current PhD students interested in science communications.

👉 Apply: https://ow.ly/85Nu50YLgIn

Fantastic 2 days in San Diego 🌴
for the inaugural C8 Early Career Investigators Symposium.

Happy to represent #TeamManchester + connect with an inspiring group 🌍.

A reminder that we’re not navigating academia alone - great to hear re: lessons learned & tips for future 🤝.

@mcrcnews.bsky.social

Join the MCRC 20th Anniversary Seminar Series keynote with Prof Richard Sullivan: “Cancer in a time of conflict”.

📅 Mon 22 June 2026, 15:00–16:30
📍Oglesby Cancer Research Building
🔗 Register: https://ow.ly/zVTC50YLeWg

📣 Early-career researchers

Apply for Broadening Horizons 2026

Cross-sector mentoring

🗓️ Apply by 1 May

🔗 static1.squarespace.com/static/612ec6ef753a9064a...

Make a difference in the oncology field & learn from experts at the forefront of fighting cancer with our MSc Transformative Oncology.

🩺 Learn from leading cancer experts
💻 Study part-time & online
🌍 Join a global cohort of healthcare professionals

https://ow.ly/BY7a50XU2pX

Matthew Harris - Manchester Cancer Research Centre Matthew Harris is a General Surgery Registrar and Leeds-Manchester CRUK Clinical Research Training Fellowship PhD student. His research focuses on the complex relationship between obesity and cancer, specifically investigating whether weight loss interventions can help reverse obesity-related cancer risk.

Meet Matthew Harris, a General Surgery Registrar & Leeds-Manchester CRUK Clinical Research Training Fellowship PhD student.

Matthew spoke to us about his research into obesity & cancer, what his typical day looks like, & his plans after his PhD. https://www.mcrc.manchester.ac.uk/matthew-harris/

PhD Myths: Debunked! 🔬

Think a PhD isn’t for you? Melville Nyatondo is breaking down misconceptions about cancer research, from funding to career paths. 🎓

We're also offering fully-funded 4-year PhDs for students from Black heritage backgrounds.

Apply here: https://ow.ly/uYOy50YeuFn

'Girls Aloud's Sarah Harding saved my life, Annette Illing says she has

Participant Annet Illing shared how the study led to her own early diagnosis - a powerful reminder of why proactive risk assessment is vital.

www.bbc.co.uk/news/article...

BBC One - Breakfast The latest news, sport, business and weather from the BBC's Breakfast team

Inspiring to see The Christie Sarah Harding Breast Cancer Appeal feature on BBC Breakfast today!

Kimberley Walsh & Dr Sacha Howell shared updates on the BCAN-RAY study, which assesses breast cancer risk in young women.

📺 Watch on iPlayer (from 08:17): www.bbc.co.uk/programmes/b...

Late Girls Aloud Singer's Life-Saving Legacy Former Girls Aloud singer Kimberley Walsh meets the first woman to be successfully treated thanks to research funded by the Sarah Harding Breast Cancer Appeal.

@drhharrison.bsky.social & @robclarkelab.bsky.social lab members were thrilled to welcome Kimberley Walsh & Annette Illing to their lab @mcrcnews.bsky.social to talk about the research we're doing in Sarah's name, funded by The Christie Charity & Sarah Harding Appeal.
bbc.co.uk/iplayer/epis...

Landmark tumour mapping could boost targeted breast and ovarian cancer therapies The researchers said the findings indicate many more patients may benefit from precision therapies

📰Landmark tumour mapping could boost targeted breast & ovarian cancer therapies @the-independent.com
Researchers, incl. Prof David Wedge from @manchester.ac.uk @mcrcnews.bsky.social said findings indicate many more patients may benefit from precision therapies www.independent.co.uk/news/health/...

A woman in a laboratory setting conducting scientific research with test tubes.

Scientists from The University of Manchester & The Institute of Cancer Research have decoded the full range of mutations driving 16 different cancers.

This 6-year study of 11k patients could help thousands more people access targeted treatments.

🔗 https://ow.ly/FQpO50YAIpL

A major milestone in the fight against glioblastoma. 🧬

Scientists have found that a pair of proteins in the blood can identify the deadliest brain tumours with high precision, even as they evolve.

Kudos to Prof. Petra Hamerlik and the team!

Full story: https://ow.ly/vIXR50Yyx05

Child lying on a medical scanner bed with a blue head support while a healthcare worker adjusts the equipment.

The Peter MacCallum Cancer Centre & Christie NHS Foundation Trust have launched an inaugural Joint International Fellowship.

This 2-year program is a career-defining bridge between two of the world's leading cancer centres.

Deadline: 7 April

Apply now: https://ow.ly/k4Xf50Yyxri

Major Milestone for Head and Neck Cancer Treatment - Manchester Cancer Research Centre - OncoDaily Major Milestone for Head and Neck Cancer Treatment - Manchester Cancer Research Centre / Anna Thompson, cancer, Catharine M West, Christopher M Nutting, Clare

Major Milestone for Head and Neck Cancer Treatment – Manchester Cancer Research Centre

@mcrcnews.bsky.social

oncodaily.com/voices/head-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Matthew Harris - Manchester Cancer Research Centre Matthew Harris is a General Surgery Registrar and Leeds-Manchester CRUK Clinical Research Training Fellowship PhD student. His research focuses on the complex relationship between obesity and cancer, specifically investigating whether weight loss interventions can help reverse obesity-related cancer risk.

Meet Matthew Harris, a General Surgery Registrar & Leeds-Manchester CRUK Clinical Research Training Fellowship PhD student.

Matthew spoke to us about his research into obesity & cancer, what his typical day looks like, & his plans after his PhD. https://www.mcrc.manchester.ac.uk/matthew-harris/

We are delighted to share that our NIHR-funded project in Kenya has been featured as a flagship impact case study by The University of Manchester. This partnership exemplifies how international cooperation can bridge the gap between laboratory research and life-saving clinical care.

Unique opportunity to spend 2 years in 2 leading #radonc centres Come and join us & research @mcrcnews.bsky.social @petermaccc.bsky.social @estroradiotherapy.bsky.social @astro-org.bsky.social @rcradiologists.bsky.social #WhereisHoskin
Closing 07/04/26
careers.petermac.org/job/MELBOURN...

Two people sitting closely inside a vintage car, the bride holding a bouquet of flowers in her lap.

Bride in a white gown holding a bouquet walks arm-in-arm with a man in a black suit down a wooden aisle during a wedding ceremony.

“I’m still super active thanks to the treatment I received"

Tex Leece is cancer free 3 years after joining a trial for oropharyngeal cancer led by Prof David Thomson at The Christie. Published in The Lancet, the study is a major milestone for proton beam therapy research.

https://ow.ly/pSC250YxttU

Eid Mubarak from all of us at the Manchester Cancer Research Centre! 🌙

Wishing happiness, peace, and prosperity to everyone celebrating. ✨

The deadline for the CRUK Black Leaders PhD Scholarship Programme is fast approaching – 3rd April!

Don’t miss out on this fully-funded 4-year opportunity for Black heritage students to make an impact in cancer research. 🎓

🔗 https://ow.ly/sJSv50YeuWm

Ageing influences tumour–niche interactions: Implications for metastatic dormancy, reawakening and recurrence Many cancer patients remain at risk of metastatic relapse for the remainder of their lives, despite initial disease remission, due to disseminated tum…

@frances-turrell.bsky.social and I have written a review! Ageing has profound impacts on many cell types and signalling pathways - how may this play a role in reawakening of dormant tumour cells and late recurrence in patients?

www.sciencedirect.com/science/arti...

@mcrcnews.bsky.social

2006 ➡️ 2026

This year, we’re celebrating two decades of Manchester‑led cancer breakthroughs. We’re marking this milestone with an exciting programme of activities and events throughout the year.

👉 Stay tuned for more info on how you can get involved:
ow.ly/nLin50YuFrE

FEBS Press This study employed machine learning methodologies to perform the subtype-specific classification of RNA-seq data sets, which are mapped on enhancers from TCGA-derived breast cancer patients. Their i...

Congratulations @sankarinagarajan.bsky.social on your lab's first article published in Molecular Oncology: Subtype-specific enhancer RNAs define transcriptional regulators and prognosis in breast cancers febs.onlinelibrary.wiley.com/doi/10.1002/...
@mcrcnews.bsky.social @mcf-uom.bsky.social

Transformative Oncology gave registered nurse Cathy Tsang the skills & knowledge to develop her career & to better understand the treatments her patients receive.

Apply to study Transformative Oncology online & part-time today: https://ow.ly/HK3i50XU2aN

PhD Myths: Debunked! 🔬

Think a PhD isn’t for you? Melville Nyatondo is breaking down misconceptions about cancer research, from funding to career paths. 🎓

We're also offering fully-funded 4-year PhDs for students from Black heritage backgrounds.

Apply here: https://ow.ly/vUoT50YeuCN

PM - Chancellor warns of possible inflation rise due to war - BBC Sounds The Chancellor responds to the economic fall-out of the US-Israel war with Iran.

This is patient-centered research in action - prioritising quality of life alongside survival. If successful, it could rewrite international guidelines.

🎧 Catch the interview on BBC Sounds (feature starts at 53:33): www.bbc.co.uk/sounds/play/...

Prof Ananya Choudhury (@achoud72.bsky.social) was on BBC Radio 4 yesterday discussing the new £3.2m ENHANCE trial (funded by @CR_UK & @prostatecanceruk.bsky.social).

The trial is testing if a half-dose of hormone therapy can maintain life-extending results while slashing debilitating side effects.

Breakthrough In A Blink - Preventing Breast Cancer In Pre-Menopausal Women A drug approved for use in other conditions could be repurposed to prevent breast cancer in women before the menopause.

A new study reveals a drug approved for use in other conditions could be repurposed to prevent breast cancer in women before the menopause.

In this short video, Non-Clinical PhD student Flor, breaks down the research findings: https://ow.ly/EXsx50Yl0Fe